These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33591879)

  • 1. High-dose benzodiazepine dependence among health-care professionals: A neglected phenomenon.
    Morbioli L; Lugoboni F
    Med Sci Law; 2021 Jan; 61(1_suppl):42-45. PubMed ID: 33591879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases.
    Faccini M; Leone R; Opri S; Casari R; Resentera C; Morbioli L; Conforti A; Lugoboni F
    J Psychopharmacol; 2016 Oct; 30(10):1047-53. PubMed ID: 27166362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena.
    File SE; Hitchcott PK
    Psychopharmacology (Berl); 1990; 101(4):525-32. PubMed ID: 1975108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mental disorders associated with benzodiazepine use among older primary care attenders--a regional survey.
    Balestrieri M; Marcon G; Samani F; Marini M; Sessa E; Gelatti U; Donato F
    Soc Psychiatry Psychiatr Epidemiol; 2005 Apr; 40(4):308-15. PubMed ID: 15834782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence on zolpidem: two case reports of detoxification with flumazenil infusion.
    Quaglio G; Lugoboni F; Fornasiero A; Lechi A; Gerra G; Mezzelani P
    Int Clin Psychopharmacol; 2005 Sep; 20(5):285-7. PubMed ID: 16096519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of patients treated with low-dose flumazenil for benzodiazepine detoxification: A description of 26 participants.
    MacDonald T; Gallo AT; Basso-Hulse G; Hulse GK
    Drug Alcohol Depend; 2022 Aug; 237():109517. PubMed ID: 35688053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of benzodiazepine withdrawal in high- and low-dose dependent psychiatric inpatients.
    Schmauss C; Apelt S; Emrich HM
    Brain Res Bull; 1987 Sep; 19(3):393-400. PubMed ID: 3676860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.
    Löscher W; Rundfeldt C; Hönack D; Ebert U
    J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The problems of long-term treatment with benzodiazepines and related substances.
    Janhsen K; Roser P; Hoffmann K
    Dtsch Arztebl Int; 2015 Jan; 112(1-2):1-7. PubMed ID: 25613443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepines revisited--will we ever learn?
    Lader M
    Addiction; 2011 Dec; 106(12):2086-109. PubMed ID: 21714826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal nonconvulsive seizures during detoxification for benzodiazepine abuse.
    Albiero A; Brigo F; Faccini M; Casari R; Quaglio G; Storti M; Fiaschi A; Bongiovanni LG; Lugoboni F
    Epilepsy Behav; 2012 Feb; 23(2):168-70. PubMed ID: 22200495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence.
    Tamburin S; Faccini M; Casari R; Federico A; Morbioli L; Franchini E; Bongiovanni LG; Lugoboni F
    J Psychopharmacol; 2017 Oct; 31(10):1369-1373. PubMed ID: 28613124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial of escalating doses of flumazenil for reversal of suspected benzodiazepine overdose in the emergency department.
    Spivey WH; Roberts JR; Derlet RW
    Ann Emerg Med; 1993 Dec; 22(12):1813-21. PubMed ID: 8239101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviating sleep-related discontinuance symptoms associated with benzodiazepine withdrawal: a new approach.
    Shapiro CM; MacFarlane JG; MacLean AW
    J Psychosom Res; 1993; 37 Suppl 1():55-7. PubMed ID: 8445587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: a protocol for a clustered, randomized clinical trial.
    Vicens C; Socias I; Mateu C; Leiva A; Bejarano F; Sempere E; Basora J; Palop V; Mengual M; Beltran JL; Aragonès E; Lera G; Folch S; Piñol JL; Esteva M; Roca M; Arenas A; Del Mar Sureda M; Campoamor F; Fiol F
    BMC Fam Pract; 2011 Apr; 12():23. PubMed ID: 21507257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precipitated abstinence in orally dosed benzodiazepine-dependent dogs.
    Martin WR; Sloan JW; Wala E
    J Pharmacol Exp Ther; 1990 Nov; 255(2):744-55. PubMed ID: 1978731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin in the discontinuation of long-term benzodiazepines' use.
    Oulis P; Konstantakopoulos G; Kouzoupis AV; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kontoangelos KA; Papadimitriou GN
    Hum Psychopharmacol; 2008 Jun; 23(4):337-40. PubMed ID: 18348245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose benzodiazepine use and QTc interval prolongation, a latent class analysis study.
    Zamboni L; Portoghese I; Casari R; Fusina F; Santin L; Lecca LI; Campagnari S; Carli S; Zandonai T; Lugoboni F
    Sci Rep; 2024 Jan; 14(1):155. PubMed ID: 38168538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users.
    Mintzer MZ; Stoller KB; Griffiths RR
    Psychopharmacology (Berl); 1999 Nov; 147(2):200-9. PubMed ID: 10591888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.